Trial · NCT02241720
Adverse events21
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 21
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Fatigue | General disorders | Regorafenib Treatment | 3 | 5 | 3 |
| other | Hypertension | Vascular disorders | Regorafenib Treatment | 4 | 5 | 4 |
| other | deydration | Metabolism and nutrition disorders | Regorafenib Treatment | 2 | 5 | 2 |
| other | Abdominal pain | Gastrointestinal disorders | Regorafenib Treatment | 1 | 5 | 2 |
| other | hyperbilirubinemia | Investigations | Regorafenib Treatment | 1 | 5 | 1 |
| other | maculopapular rash | Skin and subcutaneous tissue disorders | Regorafenib Treatment | 1 | 5 | 2 |
| other | anemia | Blood and lymphatic system disorders | Regorafenib Treatment | 1 | 5 | 1 |
| other | hypothyroidism | Endocrine disorders | Regorafenib Treatment | 1 | 5 | 1 |
| other | dysphagia | Gastrointestinal disorders | Regorafenib Treatment | 2 | 5 | 2 |
| other | headache | Nervous system disorders | Regorafenib Treatment | 1 | 5 | 1 |
| other | oral pain | Gastrointestinal disorders | Regorafenib Treatment | 1 | 5 | 1 |
| other | mucositis oral | Gastrointestinal disorders | Regorafenib Treatment | 2 | 5 | 2 |
| other | syncope | Nervous system disorders | Regorafenib Treatment | 1 | 5 | 1 |
| other | hypotension | Vascular disorders | Regorafenib Treatment | 1 | 5 | 1 |
| other | voice alteration | Respiratory, thoracic and mediastinal disorders | Regorafenib Treatment | 1 | 5 | 1 |
| other | aspiration | Respiratory, thoracic and mediastinal disorders | Regorafenib Treatment | 1 | 5 | 1 |
| other | Palmar-plantar erythrodysesthesia syndrome | Skin and subcutaneous tissue disorders | Regorafenib Treatment | 1 | 5 | 1 |
| serious | Disease Progression | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Regorafenib Treatment | 1 | 5 | 1 |
| serious | Lung infection | Infections and infestations | Regorafenib Treatment | 1 | 5 | 1 |
| serious | heart failure | Cardiac disorders | Regorafenib Treatment | 1 | 5 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02241720/events